Tailored behaviour-change programmes can help people improve and maintain medicines adherence.
Tangible improvements can be seen in clinical outcomes and treatment satisfaction if patients are involved.
Technical officer hinted that the firm has hit obstacles to its ambitious projects.
New cost-capping and delaying measures will further restrict access to new medicines say pharma and patient groups.
Pharma needs a full picture of insights from all stakeholders, including patients, from the earliest stages of the product lifecycle.
Advanced robotics, big data and 3D printing can help improve patient care and reduce costs.
Traditional ways of interacting should not be forgotten in a digital world.
Many pharma companies claim to put patients at the heart of research, but how many live up to these expectations?